IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
0.280
-0.021 (-6.82%)
At close: Mar 9, 2026, 4:00 PM EDT
0.288
+0.008 (2.86%)
After-hours: Mar 9, 2026, 7:57 PM EDT
IO Biotech Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 20 | 61 | 124 | 66 | 184 | - | |
| Market Cap Growth | -72.20% | -51.06% | 86.88% | -64.06% | - | - | |
| Enterprise Value | 8 | -18 | -39 | -82 | 268 | - | |
| Last Close Price | 0.30 | 0.92 | 1.88 | 2.30 | 6.40 | - | |
| PB Ratio | 22.99 | 1.29 | 0.93 | 0.48 | 0.87 | - | |
| P/TBV Ratio | 22.08 | 1.29 | 0.93 | 0.48 | 0.87 | - | |
| Debt / Equity Ratio | 19.89 | 0.04 | 0.02 | 0.02 | - | - | |
| Net Debt / Equity Ratio | -13.77 | -1.24 | -1.06 | -1.01 | -1.00 | -1.31 | |
| Net Debt / EBITDA Ratio | 0.14 | 0.61 | 1.54 | 1.96 | 5.13 | - | |
| Net Debt / FCF Ratio | 0.16 | 0.71 | 1.95 | 2.31 | 5.19 | 0.34 | |
| Quick Ratio | 1.73 | 3.14 | 9.18 | 13.50 | 20.73 | 1.61 | |
| Current Ratio | 2.01 | 3.33 | 9.37 | 13.88 | 21.52 | 1.85 | |
| Return on Equity (ROE) | -240.48% | -106.00% | -63.29% | -40.74% | -63.28% | -2127.56% | |
| Return on Assets (ROA) | -88.58% | -54.47% | -37.78% | -23.87% | -22.61% | -84.11% | |
| Return on Capital Employed (ROCE) | -425.30% | -197.40% | -67.70% | -50.60% | -19.50% | -389.70% | |
| Earnings Yield | -439.18% | -157.55% | -69.50% | -107.82% | -36.81% | - | |
| FCF Yield | -402.97% | -135.94% | -58.18% | -91.16% | -22.12% | - | |
| Buyback Yield / Dilution | -0.31% | -51.31% | -51.10% | -564.62% | -2346.74% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.